[go: up one dir, main page]

DE60300683D1 - Prucaloprid-n-oxid - Google Patents

Prucaloprid-n-oxid

Info

Publication number
DE60300683D1
DE60300683D1 DE60300683T DE60300683T DE60300683D1 DE 60300683 D1 DE60300683 D1 DE 60300683D1 DE 60300683 T DE60300683 T DE 60300683T DE 60300683 T DE60300683 T DE 60300683T DE 60300683 D1 DE60300683 D1 DE 60300683D1
Authority
DE
Germany
Prior art keywords
noxide
prucalopride
compositions
novel
concerned
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60300683T
Other languages
English (en)
Other versions
DE60300683T2 (de
Inventor
Joannes Adrianus Jac Schuurkes
Laerhoven Willy Joannes Ca Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Movetis NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE60300683D1 publication Critical patent/DE60300683D1/de
Application granted granted Critical
Publication of DE60300683T2 publication Critical patent/DE60300683T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE60300683T 2002-01-16 2003-01-13 Prucaloprid-n-oxid Expired - Lifetime DE60300683T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075157 2002-01-16
EP02075157 2002-01-16
PCT/EP2003/000276 WO2003059906A1 (en) 2002-01-16 2003-01-13 Prucalopride-n-oxide

Publications (2)

Publication Number Publication Date
DE60300683D1 true DE60300683D1 (de) 2005-06-23
DE60300683T2 DE60300683T2 (de) 2006-04-27

Family

ID=8185531

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60300683T Expired - Lifetime DE60300683T2 (de) 2002-01-16 2003-01-13 Prucaloprid-n-oxid

Country Status (18)

Country Link
US (2) US20050085510A1 (de)
EP (1) EP1467991B1 (de)
JP (1) JP2005514458A (de)
KR (1) KR101023433B1 (de)
CN (1) CN1330646C (de)
AT (1) ATE295845T1 (de)
AU (1) AU2003206722B2 (de)
CA (1) CA2471729C (de)
DE (1) DE60300683T2 (de)
ES (1) ES2242940T3 (de)
IL (1) IL163025A (de)
MX (1) MXPA04006888A (de)
NO (1) NO326580B1 (de)
NZ (1) NZ533041A (de)
PL (1) PL214274B1 (de)
RU (1) RU2301806C2 (de)
WO (1) WO2003059906A1 (de)
ZA (1) ZA200405654B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR058022A1 (es) * 2005-08-22 2008-01-23 Solvay Pharm Bv Derivados de benzooxazoles, composiciones farmaceuticas y su uso para el tratamiento de desordenes del sistema nervioso.
AU2006283882B2 (en) * 2005-08-22 2011-06-23 Solvay Pharmaceuticals B.V. N-oxides as prodrugs of piperazine and piperidine derivatives
US7750013B2 (en) 2005-08-22 2010-07-06 Solvay Pharmaceuticals, B.V. N-oxides as prodrugs of piperazine and piperidine derivatives
WO2007109121A2 (en) * 2006-03-16 2007-09-27 Adam Rich A zebrafish model for assessing gastrointestinal motility
EP3413891B1 (de) 2016-02-11 2024-01-03 Symed Labs Limited Verfahren zur herstellung von hochreinem prucalopridsuccinat
CN112500398A (zh) * 2020-12-24 2021-03-16 艾希尔（深圳）药物研发有限公司 一种普鲁卡必利氧化物的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716587D0 (en) * 1987-07-14 1987-08-19 Shell Int Research Preparing thiophene derivatives
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
PL182502B1 (pl) * 1994-09-27 2002-01-31 Janssen Pharmaceutica Nv Nowe związki, pochodne bicyklicznego benzoesanu N-podstawionego piperydynylu, środek farmaceutyczny i sposób wytwarzania pochodnych bicyklicznego benzoesanu N-podstawionego piperydynylu
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
TW382017B (en) * 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
NZ330263A (en) * 1996-02-15 1999-06-29 Janssen Pharmaceutica Nv Esters of 3-hydroxy-piperidinemethanol derivatives to improve gastric emptying
TW445263B (en) * 1996-02-29 2001-07-11 Janssen Pharmaceutica Nv Novel esters of 1,4-disubstituted piperidine derivatives
JP2002530334A (ja) * 1998-11-23 2002-09-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 消化不良の処置用医薬の製造のためのプルカロプリドの使用
JO2181B1 (en) * 1999-04-29 2003-04-23 شركة جانسين فارماسوتيكا ان. في Procalopride solution is taken by mouth

Also Published As

Publication number Publication date
PL370379A1 (pl) 2005-05-16
KR101023433B1 (ko) 2011-03-25
CN1330646C (zh) 2007-08-08
ES2242940T3 (es) 2005-11-16
CA2471729C (en) 2010-03-23
CA2471729A1 (en) 2003-07-24
EP1467991B1 (de) 2005-05-18
KR20040074981A (ko) 2004-08-26
NZ533041A (en) 2006-04-28
JP2005514458A (ja) 2005-05-19
AU2003206722A1 (en) 2003-07-30
MXPA04006888A (es) 2004-12-06
NO20043397L (no) 2004-08-16
DE60300683T2 (de) 2006-04-27
CN1615308A (zh) 2005-05-11
ZA200405654B (en) 2005-09-28
EP1467991A1 (de) 2004-10-20
WO2003059906A1 (en) 2003-07-24
NO326580B1 (no) 2009-01-12
PL214274B1 (pl) 2013-07-31
HK1075894A1 (zh) 2005-12-30
ATE295845T1 (de) 2005-06-15
US8063069B2 (en) 2011-11-22
IL163025A (en) 2010-06-16
RU2004124844A (ru) 2006-01-20
US20080125464A1 (en) 2008-05-29
AU2003206722B2 (en) 2008-01-24
RU2301806C2 (ru) 2007-06-27
US20050085510A1 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
CA2472954A1 (en) Aza-arylpiperazines
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
BRPI0412999A (pt) 2-aminotetralina substituìda para tratamento de depressão
TW200606147A (en) Indolyl derivatives as liver-X-receptor modulators
TW200635582A (en) Medicaments for the treatment or prevention of fibrotic diseases
BR0313747A (pt) Inibidores de transcriptase reversa de não-nucleosìdeo
SE0104341D0 (sv) New use
EA200700387A1 (ru) Гидраты и полиморфы 4-[[(7r)-8-циклопентил-7-этил-5,6,7,8-тетрагидро-5-метил-6-оксо-2-птеридинил]амино]-3-метокси-n-(1-метил-4-пиперидинил)бензамида, способы их получения и их применение в качестве лекарственных средств
BRPI0519124A2 (pt) composto, mÉtodo para tratar, prevenir ou melhorar obesidade e doenÇas relacionadas e/ou sintomas das mesmas, composiÇço farmacÊutica, uso de composto, e, combinaÇço
SE0401342D0 (sv) Therapeutic compounds
DK1546127T3 (da) Nye pyrimidinamidderivater og anvendelse deraf
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
IS2517B (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
ATE397605T1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
BRPI0411936A (pt) composto, processo para a sua preparação, composição farmacêutica que comprende o mesmo, utilização de um composto, métodos para o tratamento e profilaxia de distúrbios do sistema nervoso central, alimentares e obesidade
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
SE0102440D0 (sv) New compound
MXPA05010020A (es) Derivados de oxamida.
WO2004041802A8 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
DE60300683D1 (de) Prucaloprid-n-oxid
TW200800984A (en) New compounds
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
DE602006009556D1 (de) Chinolin-derivate zur behandlung von mglur5-rezeptor-vermittelten erkrankungen
SE0203778D0 (sv) A new oral immediated release dosage form
SE0302666D0 (sv) Novel Compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MOVETIS N.V., TURNHOUT, BE